News

Filter events

Pages

  • Anopheles gambiae mousquito. © Institut Pasteur/Paul Brey

    Press release | 23.06.2016

    Malaria - First global mapping of artemisinin resistance confirms definitively that resistance is confined to Southeast Asia and has not spread to sub-Saharan Africa

    The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falciparum malaria is for the moment confined to Southeast Asia and has not spread to sub–Saharan Africa.

  • Antibodies that are effective against both dengue and Zika viruses. Institut Pasteur

    Press release | 23.06.2016

    Antibodies that are effective against both dengue and Zika viruses

    Scientists have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. The description of the binding site for these antibodies on the viral envelope, identical for both viruses, could lead to the development of a universal vaccine that offers simultaneous protection against dengue and Zika virus disease.

  • Microscopy of a neuron. © Institut Pasteur/Christelle Durand

    Press release | 06.06.2016

    Identification of a therapeutic compound for a genetic form of autism spectrum disorders thanks to high throughput screening

    A team of researchers has highlighted the therapeutic potential of lithium in a patient with a rare form of autism spectrum disorder associated with SHANK3 gene mutation. This molecule, usually used to treat bipolar disorder, was identified thanks to high throughput screening of chemical compounds on human neurons derived from pluripotent stem cells, including those of the treated patient.

  • HIV virus particles. HIV: Identification of key immune response receptors in patients spontaneously controlling infection. © Institut Pasteur, Charles Dauguet

    Press release | 18.05.2016

    HIV: Identification of key immune response receptors in patients spontaneously controlling infection

    A small number of patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not develop the disease. The ability of these rare patients, known as "HIV controllers", to suppress HIV replication appears to be down to a highly effective immune response. Scientists observed that CD4+ T immune cells in these patients were capable of recognizing tiny quantities of the virus.

  • Meningococcal disease: identification of a sexually transmitted variant

    Press release | 12.05.2016

    Meningococcal disease: identification of a sexually transmitted variant

    A study from the University of Würzburg (Germany) and the Institut Pasteur (France) elucidates the mechanisms of the emergence of an outbreak of meningococcal disease in men who have sex with men (MSM). These results are published in the open access journal PLOS ONE.  

  • Green monkey cells infected with Zika virus seen through a transmission electron microscope. Viral particles measure 40nm in diameter. How could Zika enter Europe? © Institut Pasteur

    Press release | 25.04.2016

    How could Zika enter Europe?

    Researchers at the Institut Pasteur have assessed the transmission potential of four populations of Aedes mosquitoes in circulation on the island of Madeira and southern France with a view to examining various possible scenarios for the introduction of Zika virus to Europe. Their work suggests that the Aedes aegypti mosquito present in Madeira is more likely to promote local transmission of Zika virus than Aedes albopictus. Consequently, it appears that the risk of a Zika epidemic in continental Europe is still low.

  • A Plasmodium parasite at the sporozoite stage. Malaria: a new route of access to the heart of the parasite. © Nassira Mahmoudi

    Press release | 11.04.2016

    Malaria: a new route of access to the heart of the parasite

    Scientists have just identified an Achilles heel in the parasite that causes malaria, by showing that its optimum development is dependent on its ability to expropriate RNA molecules in infected cells – a host-pathogen interaction that had never previously been observed.

  • Lluis Quintana-Murci, Scientific Director of the Institut Pasteur. © Giovanni Cittadini Cesi

    Press release | 23.03.2016

    Lluis Quintana-Murci appointed as Scientific Director of the Institut Pasteur

    On March 23, the Institut Pasteur announced that Lluis Quintana-Murci had been appointed as Scientific Director. This new position has been created in connection with the implementation of the general strategic plan adopted by the Institut Pasteur management. Lluis Quintana-Murci, a member of the Executive Board, will serve as the person of reference and coordinator for the Institut Pasteur's scientific teams. The aim is to facilitate the formalization and day-to-day implementation of the Institut Pasteur's scientific policies and to coordinate scientific evaluation activities and related action plans.

  • Colored image of Shigella, the agent of bacillary dysentery. A genomic study of epidemic dysentery: how Europe exported a scourge worldwide. © Institut Pasteur

    Press release | 21.03.2016

    A genomic study of epidemic dysentery: how Europe exported a scourge worldwide

    Scientists at the Institut Pasteur and its International Network, the Wellcome Trust Sanger Institute (Cambridge, United Kingdom) and several international institutions have just published an exceptionally wide-ranging study tracing the history of the bacillus responsible for epidemic dysentery – one of the worst scourges to afflict humans throughout the 18th and 19th centuries. This vast scientific investigation has uncovered hitherto unknown links between the various outbreaks that have occurred through history.

  • Zika and microcephaly: first trimester of pregnancy most critical. Institut Pasteur

    Press release | 16.03.2016

    Zika and microcephaly: first trimester of pregnancy most critical

    A new analysis of data from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is around 1% for a fetus or newborn whose mother has been infected by the Zika virus during the first trimester of pregnancy.

Pages

donation_form_widget.jpg

Pasteur museum

Welcome to Pasteur Museum


musee-institut-pasteur.jpg


The Pasteur Museum is located at the Institut Pasteur, situated at: 25 rue du Docteur Roux 75015 Paris, France
 

Pasteur Museum